ArticleNanomedicine : nanotechnology, biology, and medicine2015

Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.

James Finlay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.